Miromatrix Medical

About:

Miromatrix Medical is engaged in the development of fully biological human organs and organ-derived biological products.

Website: http://miromatrix.com

Twitter/X: miromatrixmed

Top Investors: National Science Foundation, CareDx, Brightstone Venture Capital, National Institute of Diabetes and Digestive and Kidney Diseases

Description:

Miromatrix Medical is a biotechnology company engaged in the development of fully biological human organs and organ-derived biological products to solve the chronic shortage of transplantable organs, utilizing its patented perfusion decellularization or recellularization technology, as well as organ-derived biological products for applications such as soft tissue reinforcement and advanced wound care. It was founded in 2009 and is based in Eden Prairie, Minnesota.

Total Funding Amount:

$71.5M

Estimated Revenue Range:

$10M to $50M

Headquarters Location:

Eden Prairie, Minnesota, United States

Founded Date:

2009-01-01

Contact Email:

rcohen(AT)miromatrix.com

Founders:

Doris Taylor, Harald Ott

Number of Employees:

1001-5000

Last Funding Date:

2021-05-28

IPO Status:

Public

Industries:

© 2025 bioDAO.ai